Julio Vega represents public and private companies in a broad range of industries, including biotechnology, medical devices, nanotechnology, advanced materials, software, networking, e-commerce, and fintech. Julio has experience counseling clients on venture capital and other private equity financing transactions, public offerings, mergers and acquisitions, joint ventures, strategic alliances, licensing, and corporate partnering transactions. He regularly counsels clients on general corporate, employee compensation, and corporate governance matters. Julio is also very active in the representation of startup and emerging growth companies in the life sciences and technology industries.
Julio also has experience advising on international transactions and is fluent in Spanish.
Prior to joining Morgan Lewis, Julio was a partner in the emerging company, venture capital, mergers and acquisitions and securities practice of another international firm.
Licensing and Collaboration Transactions
Life Sciences Star, Financial & Corporate, LMG Life Sciences (2020–2022)
Recognized, Boston’s Most Recommended Corporate Lawyers, Companyon Ventures’ Founders Shortlist (2018)
Recognized, Life Sciences, Who’s Who Legal (2018)
Recognized, Top Latino Lawyers, Latino Leaders Magazine (2017)
Ranked, Private Equity: Venture Capital Investment, Massachusetts, Chambers USA (2007–2012, 2016–2022)
Recommended, M&A/corporate and commercial: Venture capital and emerging companies, The Legal 500 US (2018–2022)
Recommended, Finance: Capital Markets – Equity Offerings (Advice to Issuers), The Legal 500 US (2016)
Recommended, Mergers, acquisitions and buyouts - Venture capital and emerging companies, The Legal 500 US (2015)
Recommended, Corporate, The Legal 500 US (2012–2014)
Recognized, Securities/Capital Markets and Venture Capital Law, The Best Lawyers in America (2009–2012, 2015–2020, 2022, 2023)
Recognized, Biotechnology Law, The Best Lawyers in America (2009–2011, 2017)
Recognized, Massachusetts Super Lawyers (2004–2011, 2013–2014)
LMG Life Sciences Star” for outstanding transactional work, LMG Life Sciences (2012)
Recognized, Dealmakers in America, Lawdragon 500 (2007)
Ranked, Life Sciences Chambers Global (2007)
Member, American Bar Association
Member, Massachusetts Bar Association
Member, Boston Bar Association
Board of Advisers, Sequoia Pharmaceuticals Inc.